Find comprehensive information on Urinary Drug Screen (UDS) including clinical documentation requirements, medical coding guidelines (CPT, ICD-10-CM), result interpretation, and healthcare implications. Learn about UDS procedure codes, drug test panels, confirmatory testing, and documentation best practices for accurate billing and reimbursement. This resource provides essential information for physicians, nurses, and other healthcare professionals involved in ordering, performing, and interpreting urinary drug screens.
A test to detect the presence of drugs or their metabolites in urine.
Varies widely depending on the drug, from no symptoms to altered mental status, organ damage, or overdose.
Emergency rooms, addiction treatment centers, pain management clinics, workplaces.
Complete code families applicable to Z01.89
| Description | When to use |
|---|---|
| Urinary drug screen | Suspected drug misuse, overdose, monitoring compliance, pre-employment screening. |
| Drug-induced delirium | Acute confusion, altered mental status, temporal relationship to drug exposure, consider in elderly. |
| Drug dependence | Compulsive drug use despite negative consequences, withdrawal symptoms upon cessation, tolerance. |
Coding with unspecified drug class codes when a more specific code is documented leads to lower reimbursement and data inaccuracy. Impacts CDI and medical coding audits.
Coding positive drug screen results without confirmatory testing if required by policy or payer guidelines creates compliance and healthcare fraud risks.
Performing and coding urine drug screens without proper medical justification poses a significant compliance risk and may be denied by payers. Impacts medical coding and healthcare compliance.
Confirm indication for UDS (e.g., pain management, pre-op)
Verify patient consent documented
Review medication list for potential interference
Correlate UDS results with clinical picture
Document interpretation and plan in patient chart
Urinary drug screen (UDS) performed on [Date] for [Reason for testing, e.g., pre-employment screening, reasonable suspicion, monitoring compliance, post-accident investigation]. Patient provided a urine specimen, which was analyzed via [Method of analysis, e.g., immunoassay, gas chromatography-mass spectrometry] for the presence of [Specific drugs tested, e.g., amphetamines, barbiturates, benzodiazepines, cannabinoids, cocaine metabolites, opiates, methadone, PCP, tricyclic antidepressants]. Results are as follows: [List each drug tested and the result, e.g., Amphetamines: Negative; Benzodiazepines: Positive]. Chain of custody maintained per laboratory protocol. These results are consistent with [Clinical correlation and interpretation, e.g., patient's reported medication use, observed symptoms]. Plan: [Next steps based on results, e.g., further investigation, referral to substance abuse treatment, medication adjustment, documentation in patient's medical record]. ICD-10 code: [Appropriate ICD-10 code based on reason for testing and results, e.g., Z79.899 Other specified counseling, Z13.83 Encounter for screening for other drug abuse, F11.10 Opioid abuse, uncomplicated]. CPT code: [Appropriate CPT code for the specific drug panel performed, e.g., 80100, 80101, 80102, G0477, G0478, G0479]. Medical necessity for this test is supported by [Justification for testing, e.g., patient's history, clinical presentation, employer mandate]. This information will be used for patient management and may be reported to relevant parties as required by law or regulation.
Clinical accuracy: This information is provided for documentation and coding guidance and should not replace professional medical judgment.
Coding standard: ICD-10-CM, current FY guidelines.